基底性乳がんにおける遺伝子メチル化-miRNA-転写因子フィード・フォワード・ループの表遺伝子制御ネットワークの識別
Larissa M Okano1, Alexandre L K de Azevedo2, Tamyres M Carvalho2
1Research Institute Pelé Pequeno Príncipe, Faculdades Pequeno Príncipe, Curitiba 80250-060, PR, Brazil.
Cells
|August 27, 2025
まとめ
この研究は,DNAメチル化とマイクロRNAを含む表遺伝的変化が,基礎性乳がん (BLBC) の複雑な規制ネットワークを作成する方法を示しています. これらの発見は,BLBCの進行の主要な原動力としてフィード・フォワード・ループ (FFL) を強調し,潜在的な治療目標を提供します.
科学分野:
- * エピジェネティクスとガンゲノミクス
- * 分子生物学とバイオインフォマティクス
- * 規制ネットワーク分析
背景:
- * 基礎性乳がん (BLBC) は,分子複雑性と異質性により,臨床的に重要な課題を提示する.
- * エピジェネティック変異,特にDNAメチル化がBLBCの病原性に関与しているが,規制メカニズムについてより深い調査が必要である.
- * これらのメカニズムの理解は,この攻撃的ながんサブタイプの標的治療の開発に不可欠です.
研究 の 目的:
- * BLBCにおける表遺伝的調節ネットワークを調査し,ディスタルシス調節領域におけるDNAメチル化に焦点を当てた.
- * 遺伝子,転写因子 (TF),およびマイクロRNA (miRNA) 発現に対するこれらの表遺伝的変化の影響を分析する.
- BLBCの発展と進行を統括するフィード・フォワード・ループ (FFL) などの主要な規制動機を特定する.
主な方法:
- * 癌ゲノムアトラス (TCGA) のデータを総合的に分析した.
- * 異なったメチル化領域と異なった発現遺伝子,TFs,miRNAsを特定するためにELMERとDESeq2ツールを使用した.
- * FANMODアルゴリズムを使用して,TFおよびmiRNA媒介のフィードフォワードループ (FFL) および複合FFLを検出した.
主要な成果:
- * BLBCで110のTF媒介FFL,43のmiRNA媒介FFL,5つの複合FFLを特定した.
- * 遺伝子のメチル化 (18 種,低メチル化32 種),TF発現 (8 種,低調9 種),miRNA発現 (21 種,低調7 種) の有意な変化が検出されました.
- * 主な調節因子には,AR,FOXM1,TEAD4などのTF,miR- 429,miR- 4434などのmiRNAが含まれており,RasやTGF- betaのシグナル伝達に影響を及ぼしています.
結論:
- * この統合的分析は,BLBCの複雑な表遺伝的景観を明らかにし,FFLの重要な役割を強調しています.
- * FFLは,BLBCの病原性におけるDNAメチル化,TF,およびmiRNAを統合する中心的な調節モチーフとして機能する.
- * 特定された規制ネットワークと主要プレーヤーは,BLBCにおける将来の診断と治療戦略の有望なターゲットを提供します.
関連する概念動画
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
MicroRNAs
21.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.7K
Master Transcription Regulators
7.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


